Survival and determinants of mortality in adult HIV/Aids patients initiating antiretroviral therapy in Somali Region, Eastern Ethiopia

被引:42
作者
Damtew, Bereket [1 ]
Mengistie, Bezatu [2 ]
Alemayehu, Tadesse [2 ]
机构
[1] Haramaya Univ, Dept Epidemiol & Biostat, Coll Hlth & Med Sci, East Harerge, Ethiopia
[2] Haramaya Univ, Dept Publ Hlth, Coll Hlth & Med Sci, East Harerge, Ethiopia
来源
PAN AFRICAN MEDICAL JOURNAL | 2015年 / 22卷
关键词
HIV; Aids; antiretroviral therapy; Ethiopia;
D O I
10.11604/pamj.2015.22.138.4352
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Introduction: Studies have shown high initial mortality in Antiretroviral Therapy (ART) programs from resource-limited settings. However, there is dearth of evidence on treatment outcomes and associated determinant factors in public hospitals. Therefore, the objective of this study is to assess survival and identify predictors of death in adult HIV-infected patients initiating ART at a public hospital in Eastern Ethiopia. Methods: A retrospective cohort study was conducted by reviewing baseline and follow-up records of patients who started ART between December 1, 2007 and December 31, 2011 at Kharamara hospital. Time to death was the main outcome measure. Kaplan-Meier models were used to estimate mortality and Cox proportional hazards models to identify predictors of mortality. Results: A total of 784 patients (58.4% females) were followed for a median of 60 months. There were 87 (11.1%) deaths yielding an overall mortality rate of 5.15/100 PYO (95% CI: 4.73-6.37). The estimated mortality was 8.4%, 9.8%, 11.3%, 12.7% and 14.1% at 6, 12, 24, 36 and 48 months respectively. The independent predictors of death were single marital status (AHR: 2.31; 95% CI: 1.18-4.50), a bedridden functional status (AHR: 5.91; 95% CI: 2.87-12.16), advanced WHO stage (AHR: 7.36; 95% CI: 3.17-17.12), BMI < 18.5 Kg/m(2) (AHR: 2.20; 95% CI: 1.18-4.09), CD4 count < 50 cells/mu L (AHR: 2.70; 95% CI: 1.26-5.80), severe anemia (AHR: 4.57; 95% CI: 2.30-9.10), and TB co-infection (AHR: 2.30; 95% CI: 1.28-4.11). Conclusion: Improved survival was observed in patients taking ART in Somali region of Ethiopia. The risk for death was higher in patients with advanced WHO stage, low CD4 count, low Hgb, low BMI, and concomitant TB infection. Intensive case management is recommended for patients with the prognostic factors. Optimal immunologic and weight recoveries in the first 6 months suggest increased effort to retain patients in care at this period.
引用
收藏
页数:8
相关论文
共 22 条
  • [11] Predictors of mortality in HIV-infected patients starting antiretroviral therapy in a rural hospital in Tanzania
    Johannessen, Asgeir
    Naman, Ezra
    Ngowi, Bernard J.
    Sandvik, Leiv
    Matee, Mecky I.
    Aglen, Henry E.
    Gundersen, Svein G.
    Bruun, Johan N.
    [J]. BMC INFECTIOUS DISEASES, 2008, 8 (1)
  • [12] Further benefits by early start of HIV treatment in low income countries: Survival estimates of early versus deferred antiretroviral therapy
    Johansson, Kjell Arne
    Robberstad, Bjarne
    Norheim, Ole Frithjof
    [J]. AIDS RESEARCH AND THERAPY, 2010, 7
  • [13] Treatment of Active Tuberculosis in HIV-Coinfected Patients: A Systematic Review and Meta-Analysis
    Khan, Faiz A.
    Minion, Jessica
    Pai, Madhukar
    Royce, Sarah
    Burman, William
    Harries, Anthony D.
    Menzies, Dick
    [J]. CLINICAL INFECTIOUS DISEASES, 2010, 50 (09) : 1288 - 1299
  • [14] Kigozi BK, 2009, AIDS RES THER, V6, P1
  • [15] CD4 cell count recovery among HIV-infected patients with very advanced immunodeficiency commencing antiretroviral treatment in sub-Saharan Africa
    Lawn, SD
    Myer, L
    Bekker, LG
    Wood, R
    [J]. BMC INFECTIOUS DISEASES, 2006, 6 (1)
  • [16] Survival rate and risk factors of mortality among HIV/tuberculosis-coinfected patients with and without antiretroviral therapy
    Manosuthi, Weerawat
    Chottanapand, Suthat
    Thongyen, Supeda
    Chaovavanich, Achara
    Sungkanuparph, Somnuek
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2006, 43 (01) : 42 - 46
  • [17] Ojikutu B, 2008, SAMJ S AFR MED J, V98, P204
  • [18] Tsegaye E, 2011, ETHIOP J HEALTH DEV, V25, P102
  • [19] UNAIDS, 2012, REP GLOB AIDS EP 201
  • [20] Body mass index at time of HIV diagnosis - A strong and independent predictor of survival
    van der Sande, MAB
    van der Loeff, MFS
    Aveika, AA
    Sabally, S
    Togun, T
    Sarge-Njie, R
    Alabi, AS
    Jaye, A
    Corrah, T
    Whittle, HC
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2004, 37 (02) : 1288 - 1294